List of Tables
Table 1. Global Anti-GFP Nanobody Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Anti-GFP Nanobody Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Anti-GFP Nanobody Market Competitive Situation by Manufacturers in 2023
Table 4. Global Anti-GFP Nanobody Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Anti-GFP Nanobody Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Anti-GFP Nanobody Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Anti-GFP Nanobody Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Anti-GFP Nanobody Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Anti-GFP Nanobody, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anti-GFP Nanobody, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-GFP Nanobody, Product Type & Application
Table 12. Global Key Manufacturers of Anti-GFP Nanobody, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-GFP Nanobody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-GFP Nanobody as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-GFP Nanobody Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Anti-GFP Nanobody Sales by Region (2019-2024) & (K Units)
Table 18. Global Anti-GFP Nanobody Sales Market Share by Region (2019-2024)
Table 19. Global Anti-GFP Nanobody Sales by Region (2025-2030) & (K Units)
Table 20. Global Anti-GFP Nanobody Sales Market Share by Region (2025-2030)
Table 21. Global Anti-GFP Nanobody Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Anti-GFP Nanobody Revenue Market Share by Region (2019-2024)
Table 23. Global Anti-GFP Nanobody Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Anti-GFP Nanobody Revenue Market Share by Region (2025-2030)
Table 25. North America Anti-GFP Nanobody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Anti-GFP Nanobody Sales by Country (2019-2024) & (K Units)
Table 27. North America Anti-GFP Nanobody Sales by Country (2025-2030) & (K Units)
Table 28. North America Anti-GFP Nanobody Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Anti-GFP Nanobody Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Anti-GFP Nanobody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Anti-GFP Nanobody Sales by Country (2019-2024) & (K Units)
Table 32. Europe Anti-GFP Nanobody Sales by Country (2025-2030) & (K Units)
Table 33. Europe Anti-GFP Nanobody Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Anti-GFP Nanobody Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Anti-GFP Nanobody Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Anti-GFP Nanobody Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Anti-GFP Nanobody Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Anti-GFP Nanobody Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Anti-GFP Nanobody Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Anti-GFP Nanobody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Anti-GFP Nanobody Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Anti-GFP Nanobody Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Anti-GFP Nanobody Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Anti-GFP Nanobody Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Anti-GFP Nanobody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Anti-GFP Nanobody Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Anti-GFP Nanobody Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Anti-GFP Nanobody Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Anti-GFP Nanobody Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Anti-GFP Nanobody Sales (K Units) by Type (2019-2024)
Table 51. Global Anti-GFP Nanobody Sales (K Units) by Type (2025-2030)
Table 52. Global Anti-GFP Nanobody Sales Market Share by Type (2019-2024)
Table 53. Global Anti-GFP Nanobody Sales Market Share by Type (2025-2030)
Table 54. Global Anti-GFP Nanobody Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Anti-GFP Nanobody Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Anti-GFP Nanobody Revenue Market Share by Type (2019-2024)
Table 57. Global Anti-GFP Nanobody Revenue Market Share by Type (2025-2030)
Table 58. Global Anti-GFP Nanobody Price (US$/Unit) by Type (2019-2024)
Table 59. Global Anti-GFP Nanobody Price (US$/Unit) by Type (2025-2030)
Table 60. Global Anti-GFP Nanobody Sales (K Units) by Application (2019-2024)
Table 61. Global Anti-GFP Nanobody Sales (K Units) by Application (2025-2030)
Table 62. Global Anti-GFP Nanobody Sales Market Share by Application (2019-2024)
Table 63. Global Anti-GFP Nanobody Sales Market Share by Application (2025-2030)
Table 64. Global Anti-GFP Nanobody Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Anti-GFP Nanobody Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Anti-GFP Nanobody Revenue Market Share by Application (2019-2024)
Table 67. Global Anti-GFP Nanobody Revenue Market Share by Application (2025-2030)
Table 68. Global Anti-GFP Nanobody Price (US$/Unit) by Application (2019-2024)
Table 69. Global Anti-GFP Nanobody Price (US$/Unit) by Application (2025-2030)
Table 70. Sino Biological Company Information
Table 71. Sino Biological Description and Business Overview
Table 72. Sino Biological Anti-GFP Nanobody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Sino Biological Anti-GFP Nanobody Product
Table 74. Sino Biological Recent Developments/Updates
Table 75. GenScript Company Information
Table 76. GenScript Description and Business Overview
Table 77. GenScript Anti-GFP Nanobody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. GenScript Anti-GFP Nanobody Product
Table 79. GenScript Recent Developments/Updates
Table 80. Proteintech Group Company Information
Table 81. Proteintech Group Description and Business Overview
Table 82. Proteintech Group Anti-GFP Nanobody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Proteintech Group Anti-GFP Nanobody Product
Table 84. Proteintech Group Recent Developments/Updates
Table 85. Abiocenter Company Information
Table 86. Abiocenter Description and Business Overview
Table 87. Abiocenter Anti-GFP Nanobody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Abiocenter Anti-GFP Nanobody Product
Table 89. Abiocenter Recent Developments/Updates
Table 90. MerryBio Company Information
Table 91. MerryBio Description and Business Overview
Table 92. MerryBio Anti-GFP Nanobody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. MerryBio Anti-GFP Nanobody Product
Table 94. MerryBio Recent Developments/Updates
Table 95. Pregene Company Information
Table 96. Pregene Description and Business Overview
Table 97. Pregene Anti-GFP Nanobody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Pregene Anti-GFP Nanobody Product
Table 99. Pregene Recent Developments/Updates
Table 100. Cusabio Company Information
Table 101. Cusabio Description and Business Overview
Table 102. Cusabio Anti-GFP Nanobody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Cusabio Anti-GFP Nanobody Product
Table 104. Cusabio Recent Developments/Updates
Table 105. Biocytogen Company Information
Table 106. Biocytogen Description and Business Overview
Table 107. Biocytogen Anti-GFP Nanobody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Biocytogen Anti-GFP Nanobody Product
Table 109. Biocytogen Recent Developments/Updates
Table 110. Thermo Fisher Scientific Company Information
Table 111. Thermo Fisher Scientific Description and Business Overview
Table 112. Thermo Fisher Scientific Anti-GFP Nanobody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Thermo Fisher Scientific Anti-GFP Nanobody Product
Table 114. Thermo Fisher Scientific Recent Developments/Updates
Table 115. QVQuality Company Information
Table 116. QVQuality Description and Business Overview
Table 117. QVQuality Anti-GFP Nanobody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. QVQuality Anti-GFP Nanobody Product
Table 119. QVQuality Recent Developments/Updates
Table 120. HUABIO Company Information
Table 121. HUABIO Description and Business Overview
Table 122. HUABIO Anti-GFP Nanobody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. HUABIO Anti-GFP Nanobody Product
Table 124. HUABIO Recent Developments/Updates
Table 125. Jackson ImmunoResearch Company Information
Table 126. Jackson ImmunoResearch Description and Business Overview
Table 127. Jackson ImmunoResearch Anti-GFP Nanobody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Jackson ImmunoResearch Anti-GFP Nanobody Product
Table 129. Jackson ImmunoResearch Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Anti-GFP Nanobody Distributors List
Table 133. Anti-GFP Nanobody Customers List
Table 134. Anti-GFP Nanobody Market Trends
Table 135. Anti-GFP Nanobody Market Drivers
Table 136. Anti-GFP Nanobody Market Challenges
Table 137. Anti-GFP Nanobody Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Anti-GFP Nanobody
Figure 2. Global Anti-GFP Nanobody Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Anti-GFP Nanobody Market Share by Type: 2023 & 2030
Figure 4. Monovalent Nanobodies Product Picture
Figure 5. Bivalent Nanobodies Product Picture
Figure 6. Bispecific Nanobodies Product Picture
Figure 7. Multivalent Nanobodies Product Picture
Figure 8. Fused Nanobodies Product Picture
Figure 9. Global Anti-GFP Nanobody Market Value by Application (2024-2030) & (US$ Million)
Figure 10. Global Anti-GFP Nanobody Market Share by Application: 2023 & 2030
Figure 11. Immunoprecipitation
Figure 12. Chromatin Immunoprecipitation
Figure 13. RNA Binding Protein Immunoprecipitation
Figure 14. Other
Figure 15. Global Anti-GFP Nanobody Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Anti-GFP Nanobody Market Size (2019-2030) & (US$ Million)
Figure 17. Global Anti-GFP Nanobody Sales (2019-2030) & (K Units)
Figure 18. Global Anti-GFP Nanobody Average Price (US$/Unit) & (2019-2030)
Figure 19. Anti-GFP Nanobody Report Years Considered
Figure 20. Anti-GFP Nanobody Sales Share by Manufacturers in 2023
Figure 21. Global Anti-GFP Nanobody Revenue Share by Manufacturers in 2023
Figure 22. Global 5 and 10 Largest Anti-GFP Nanobody Players: Market Share by Revenue in Anti-GFP Nanobody in 2023
Figure 23. Anti-GFP Nanobody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 24. Global Anti-GFP Nanobody Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America Anti-GFP Nanobody Sales Market Share by Country (2019-2030)
Figure 26. North America Anti-GFP Nanobody Revenue Market Share by Country (2019-2030)
Figure 27. United States Anti-GFP Nanobody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada Anti-GFP Nanobody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe Anti-GFP Nanobody Sales Market Share by Country (2019-2030)
Figure 30. Europe Anti-GFP Nanobody Revenue Market Share by Country (2019-2030)
Figure 31. Germany Anti-GFP Nanobody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France Anti-GFP Nanobody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. Anti-GFP Nanobody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy Anti-GFP Nanobody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Russia Anti-GFP Nanobody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Anti-GFP Nanobody Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific Anti-GFP Nanobody Revenue Market Share by Region (2019-2030)
Figure 38. China Anti-GFP Nanobody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan Anti-GFP Nanobody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea Anti-GFP Nanobody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India Anti-GFP Nanobody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia Anti-GFP Nanobody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. China Taiwan Anti-GFP Nanobody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Anti-GFP Nanobody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Anti-GFP Nanobody Sales Market Share by Country (2019-2030)
Figure 46. Mexico Anti-GFP Nanobody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Anti-GFP Nanobody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Anti-GFP Nanobody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Colombia Anti-GFP Nanobody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East and Africa Anti-GFP Nanobody Sales Market Share by Country (2019-2030)
Figure 51. Middle East and Africa Anti-GFP Nanobody Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Anti-GFP Nanobody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Anti-GFP Nanobody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Anti-GFP Nanobody Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Anti-GFP Nanobody by Type (2019-2030)
Figure 56. Global Revenue Market Share of Anti-GFP Nanobody by Type (2019-2030)
Figure 57. Global Anti-GFP Nanobody Price (US$/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Anti-GFP Nanobody by Application (2019-2030)
Figure 59. Global Revenue Market Share of Anti-GFP Nanobody by Application (2019-2030)
Figure 60. Global Anti-GFP Nanobody Price (US$/Unit) by Application (2019-2030)
Figure 61. Anti-GFP Nanobody Value Chain
Figure 62. Anti-GFP Nanobody Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
